Matt serves as the head of clinical development operations at BrYet leading efforts to bring our products into the clinic and execute our clinical trials. Matt has over 20 years of industry experience working across Biotech, CRO, and site organizations in areas including clinical development operations, business operations, and business development. Matt has spent most of his career focused on bringing novel oncology therapeutics and diagnostics to patients.

Previously, he was the Sr. Director of Clinical Operations at Kiromic BioPharma, an immune-oncology focused cell therapy company. He also held executive and management roles at small and mid-sized CROs building clinical operations teams at Proxima, MedSource, and US Oncology Clinical Development. In addition, he previously led clinical development for the GI, Lung, Hematology, and Radiation oncology research programs within the US Oncology Research network – the largest community oncology network in the United States – and spent time running clinical trials in academic institutions including MD Anderson Cancer Center and the University of Texas Medical Branch.

Matt also serves as a Co-founder of AccelSoBio, a clinical services and consulting organization focused on serving the biotech and medical device industry with a focus on oncology.  Matt is based out of Houston, TX and he recieved his bachelors degree in biomedical science from Texas A&M University.